Landscape Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-99,985
Closed -$993K 940
2022
Q3
$993K Buy
99,985
+700
+0.7% +$6.93K 0.13% 133
2022
Q2
$977K Hold
99,285
0.13% 130
2022
Q1
$973K Sell
99,285
-14,958
-13% -$148K 0.12% 141
2021
Q4
$1.13M Sell
114,243
-32,145
-22% -$319K 0.16% 121
2021
Q3
$1.45M Buy
146,388
+135,883
+1,294% +$1.33M 0.2% 99
2021
Q2
$102K Buy
+10,505
New +$103K 0.01% 607

Other funds holding TLSI

Landscape Capital Management's TLSI Position: Q4 2022 in Review

Landscape Capital Management sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 99,985 shares — an estimated $993K sold.

Landscape Capital Management first reported a position in TLSI in Q2 2021 and held it in 6 quarters. The position peaked at $1.45M in Q3 2021. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • Landscape Capital Management reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Landscape Capital Management sold 99,985 TriSalus Life Sciences shares in Q4 2022, an estimated $993K.
  • Landscape Capital Management first reported a position in TriSalus Life Sciences in Q2 2021 and held it in 6 quarters.
  • Landscape Capital Management's TriSalus Life Sciences position peaked at $1.45M in Q3 2021.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Landscape Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.